South Korea Drug Price Cuts Show Impact In Latest Pharma Quarterlies
This article was originally published in PharmAsia News
Executive Summary
South Korea’s recent price controls have affected the second-quarter bottom lines of several local drug makers, they said, although some also reported increased production costs.